I like this market review you regularly post. Reminds us all of the bigger picture. Though could you add something to it focused on the biotech market that Imugene occupies and how that is trending, in Australia and globally. I noticed yesterday that quite a few smaller Oz biotech have taken a hit, including those that are in solid financial positions with stead reliable earnings.
IMU Price at posting:
1.8¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)